242 related articles for article (PubMed ID: 8260728)
1. William L. McGuire Memorial Symposium. Estrogen and progestin effects in human breast carcinogenesis.
King RJ
Breast Cancer Res Treat; 1993; 27(1-2):3-15. PubMed ID: 8260728
[TBL] [Abstract][Full Text] [Related]
2. Biology of female sex hormone action in relation to contraceptive agents and neoplasia.
King RJ
Contraception; 1991 Jun; 43(6):527-42. PubMed ID: 1651204
[TBL] [Abstract][Full Text] [Related]
3. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.
Pike MC; Spicer DV; Dahmoush L; Press MF
Epidemiol Rev; 1993; 15(1):17-35. PubMed ID: 8405201
[TBL] [Abstract][Full Text] [Related]
4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
5. A discussion of the roles of oestrogen and progestin in human mammary carcinogenesis.
King RJ
J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):811-8. PubMed ID: 1954171
[TBL] [Abstract][Full Text] [Related]
6. Exogenous progestins and breast cancer.
Stanford JL; Thomas DB
Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
[TBL] [Abstract][Full Text] [Related]
7. Progestins and antiprogestins in mammary tumour growth and metastasis.
Shi YE; Liu YE; Lippman ME; Dickson RB
Hum Reprod; 1994 Jun; 9 Suppl 1():162-73. PubMed ID: 7962461
[TBL] [Abstract][Full Text] [Related]
8. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation.
Jeng MH; Parker CJ; Jordan VC
Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300
[TBL] [Abstract][Full Text] [Related]
9. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
[TBL] [Abstract][Full Text] [Related]
10. Progestins and breast cancer: an epidemiologic review.
Staffa JA; Newschaffer CJ; Jones JK; Miller V
Fertil Steril; 1992 Mar; 57(3):473-91. PubMed ID: 1740192
[TBL] [Abstract][Full Text] [Related]
11. The estrogenic activity of synthetic progestins used in oral contraceptives.
Jordan VC; Jeng MH; Catherino WH; Parker CJ
Cancer; 1993 Feb; 71(4 Suppl):1501-5. PubMed ID: 8431886
[TBL] [Abstract][Full Text] [Related]
12. Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions.
van der Burg B; Kalkhoven E; Isbrücker L; de Laat SW
J Steroid Biochem Mol Biol; 1992 Jun; 42(5):457-65. PubMed ID: 1616875
[TBL] [Abstract][Full Text] [Related]
13. The adverse effects of hormonal therapy.
Bush TL
Cardiol Clin; 1986 Feb; 4(1):145-52. PubMed ID: 3518931
[TBL] [Abstract][Full Text] [Related]
14. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
van Leeuwen FE
Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
[TBL] [Abstract][Full Text] [Related]
15. Risk of breast cancer with progestins: critical assessment of current data.
Santen RJ
Steroids; 2003 Nov; 68(10-13):953-64. PubMed ID: 14667988
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and progestin regulation of cell cycle progression.
Sutherland RL; Prall OW; Watts CK; Musgrove EA
J Mammary Gland Biol Neoplasia; 1998 Jan; 3(1):63-72. PubMed ID: 10819505
[TBL] [Abstract][Full Text] [Related]
17. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
van den Berg HW; Martin J; Lynch M
Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
19. Risks and mechanisms of cardiovascular events in users of oral contraceptives.
Meade TW
Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1646-52. PubMed ID: 3287935
[TBL] [Abstract][Full Text] [Related]
20. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
